Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence

2012 ◽  
Vol 83 (3) ◽  
pp. 407-421 ◽  
Author(s):  
Sai-Hong Ignatius Ou
Sign in / Sign up

Export Citation Format

Share Document